{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:58:51Z","timestamp":1779933531277,"version":"3.53.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","oralmaxsurgery.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.coms.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T04:46:07Z","timestamp":1469681167000},"page":"409-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Medication Treatment Efficacy and Chronic Orofacial Pain"],"prefix":"10.1016","volume":"28","author":[{"given":"Glenn T.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.coms.2016.03.011_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.14219\/jada.archive.2000.0146","article-title":"Topical medications for orofacial neuropathic pain: a review","volume":"131","author":"Padilla","year":"2000","journal-title":"J\u00a0Am Dent Assoc"},{"issue":"3","key":"10.1016\/j.coms.2016.03.011_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cden.2013.04.011","article-title":"Topical medications as treatment of neuropathic orofacial pain","volume":"57","author":"Nasri-Heir","year":"2013","journal-title":"Dent Clin North Am"},{"issue":"6","key":"10.1016\/j.coms.2016.03.011_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.14219\/jada.archive.2013.0172","article-title":"Topical medications for the effective management of neuropathic orofacial pain","volume":"144","author":"Haribabu","year":"2013","journal-title":"J\u00a0Am Dent Assoc"},{"issue":"3","key":"10.1016\/j.coms.2016.03.011_bib4","first-page":"200","article-title":"Topical medications for orofacial neuropathic pain","volume":"14","author":"Bramwell","year":"2010","journal-title":"Int J Pharm Compd"},{"issue":"8","key":"10.1016\/j.coms.2016.03.011_bib5","first-page":"645","article-title":"Using oral medications, infusions and injections for differential diagnosis of orofacial pain","volume":"34","author":"Ram","year":"2006","journal-title":"J\u00a0Calif Dent Assoc"},{"issue":"8","key":"10.1016\/j.coms.2016.03.011_bib6","first-page":"599","article-title":"Persistent orodental pain, atypical odontalgia, and phantom tooth pain: when are they neuropathic disorders?","volume":"34","author":"Clark","year":"2006","journal-title":"J\u00a0Calif Dent Assoc"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40122-015-0032-z","article-title":"Skin matters: a review of topical treatments for chronic pain. Part two: treatments and applications","volume":"4","author":"Peppin","year":"2015","journal-title":"Pain Ther"},{"issue":"2","key":"10.1016\/j.coms.2016.03.011_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.coms.2016.03.011_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010958","article-title":"Topical lidocaine for neuropathic pain in adults","author":"Derry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1\u20132","key":"10.1016\/j.coms.2016.03.011_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(03)00317-8","article-title":"Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study","volume":"106","author":"Meier","year":"2003","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.coms.2016.03.011_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tripleo.2007.09.030","article-title":"Use of topical medication in orofacial neuropathic pain: a retrospective study","volume":"105","author":"Heir","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.coms.2016.03.011_bib12","doi-asserted-by":"crossref","first-page":"574526","DOI":"10.1155\/2013\/574526","article-title":"An emerging dimension in psychosomatic research: the nocebo phenomenon in the management of chronic pain","volume":"2013","author":"Ciaramella","year":"2013","journal-title":"ISRN Neurosci"},{"issue":"5","key":"10.1016\/j.coms.2016.03.011_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/AJP.0b013e3182321ad8","article-title":"Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review","volume":"28","author":"H\u00e4user","year":"2012","journal-title":"Clin J Pain"},{"issue":"7","key":"10.1016\/j.coms.2016.03.011_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.clinthera.2010.07.014","article-title":"Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: findings from a cost-consequences analysis in a nested case-control study","volume":"32","author":"P\u00e9rez","year":"2010","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011605","article-title":"Nortriptyline for neuropathic pain in adults","author":"Derry","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.coms.2016.03.011_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010692.pub2","article-title":"Oxycodone for\u00a0neuropathic pain and fibromyalgia in adults","author":"Gaskell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.coms.2016.03.011_bib17","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/j.pain.0000000000000149","article-title":"Combination of morphine with nortriptyline for neuropathic pain","volume":"156","author":"Gilron","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.coms.2016.03.011_bib18","unstructured":"Federal Register\/Vol. 79, No. 127\/Wednesday, July 2, 2014\/Rules and Regulations pages 37623\u20139."},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/head.12210","article-title":"Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT\/Nap","volume":"54","author":"Cady","year":"2014","journal-title":"Headache"},{"issue":"17","key":"10.1016\/j.coms.2016.03.011_bib20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3182535d0c","article-title":"Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Holland","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.coms.2016.03.011_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0002-9343(01)00762-8","article-title":"Treatment of chronic headache with antidepressants: a meta-analysis","volume":"111","author":"Tomkins","year":"2001","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.coms.2016.03.011_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1586\/17512433.2014.885835","article-title":"Efficacy and mechanism of anticonvulsant drugs in migraine","volume":"7","author":"Hoffmann","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.coms.2016.03.011_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010611","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.coms.2016.03.011_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002761","article-title":"Drugs for preventing migraine headaches in children","author":"Victor","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.coms.2016.03.011_bib25","article-title":"Topiramate for the prophylaxis of episodic migraine\u00a0in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.coms.2016.03.011_bib26","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/1060028014548872","article-title":"Memantine for the prevention of primary headache disorders","volume":"48","author":"Huang","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.coms.2016.03.011_bib27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/0333102414547138","article-title":"Adherence to oral migraine-preventive medications among patients with chronic migraine","volume":"35","author":"Hepp","year":"2015","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.coms.2016.03.011_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11606-014-3107-3","article-title":"Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS Data 1999-2010","volume":"30","author":"Mafi","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"issue":"11","key":"10.1016\/j.coms.2016.03.011_bib29","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1468-1331.2010.03070.x","article-title":"EFNS guideline on the treatment of tension-type headache - report of an EFNS task force","volume":"17","author":"Bendtsen","year":"2010","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13075-015-0530-8","article-title":"Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin or pregabalin in fibromyalgia","volume":"17","author":"Kim","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.coms.2016.03.011_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/11598970-000000000-00000","article-title":"The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis","volume":"26","author":"H\u00e4user","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.coms.2016.03.011_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia\u2013responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"10.1016\/j.coms.2016.03.011_bib33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.5114\/aoms.2013.39617","article-title":"A\u00a0systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience","volume":"9","author":"Keshavarz","year":"2013","journal-title":"Arch Med Sci"},{"issue":"5","key":"10.1016\/j.coms.2016.03.011_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s13075-014-0451-y","article-title":"Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial","volume":"16","author":"Luciano","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.coms.2016.03.011_bib35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ejp.564","article-title":"More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms","volume":"18","author":"Perrot","year":"2014","journal-title":"Eur J Pain"},{"issue":"5","key":"10.1016\/j.coms.2016.03.011_bib36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/ALN.0000000000000637","article-title":"Fibromyalgia Survey criteria is associated with increased postoperative opioid consumption in women undergoing hysterectomy","volume":"122","author":"Janda","year":"2015","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/AJP.0000000000000079","article-title":"Long-term evaluation of opioid treatment in fibromyalgia","volume":"31","author":"Peng","year":"2015","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/bja\/aet351","article-title":"Chronic widespread pain, including fibromyalgia: a pathway for care developed by the British Pain Society","volume":"112","author":"Lee","year":"2014","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.coms.2016.03.011_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007261.pub2","article-title":"Interventions for the management of temporomandibular joint osteoarthritis","author":"de Souza","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3121\/cmr.2007.698","article-title":"An evidence-based update on nonsteroidal anti-inflammatory drugs","volume":"5","author":"Ong","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.coms.2016.03.011_bib41","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.20698","article-title":"A\u00a0comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis","volume":"51","author":"Lee","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.coms.2016.03.011_bib42","first-page":"321","article-title":"Temporomandibular joint injection with corticosteroid and local anesthetic for limited mouth opening","volume":"53","author":"Samiee","year":"2011","journal-title":"J\u00a0Oral Sci"},{"issue":"8","key":"10.1016\/j.coms.2016.03.011_bib43","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.joms.2011.11.003","article-title":"Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis","volume":"70","author":"Stoll","year":"2012","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.coms.2016.03.011_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005328.pub2","article-title":"Intraarticular corticosteroid for treatment of osteoarthritis of\u00a0the knee","author":"Bellamy","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.coms.2016.03.011_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clim.2012.12.011","article-title":"Immunopathogenesis of osteoarthritis","volume":"146","author":"Haseeb","year":"2013","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib46","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3390\/ijms16010887","article-title":"Cytokine-modulating strategies and newer cytokine targets for arthritis therapy","volume":"16","author":"Venkatesha","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.coms.2016.03.011_bib47","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4161\/hv.27910","article-title":"Emerging immunotherapies for rheumatoid arthritis","volume":"10","author":"Reynolds","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int Immunol"},{"issue":"11","key":"10.1016\/j.coms.2016.03.011_bib49","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/ket256","article-title":"Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies","volume":"52","author":"Vidqvist","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.coms.2016.03.011_bib50","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/03009740701607067","article-title":"The\u00a0number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review","volume":"36","author":"Kristensen","year":"2007","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.coms.2016.03.011_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00482-014-1451-1","article-title":"Opioids in chronic osteoarthritis pain: a systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration","volume":"29","author":"Schaefert","year":"2015","journal-title":"Schmerz"},{"issue":"11","key":"10.1016\/j.coms.2016.03.011_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003113.pub3","article-title":"Opioid therapy for treating rheumatoid arthritis pain","author":"Whittle","year":"2011","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369916300188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369916300188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T16:56:05Z","timestamp":1568220965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042369916300188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1042369916300188"],"URL":"https:\/\/doi.org\/10.1016\/j.coms.2016.03.011","relation":{},"ISSN":["1042-3699"],"issn-type":[{"value":"1042-3699","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication Treatment Efficacy and Chronic Orofacial Pain","name":"articletitle","label":"Article Title"},{"value":"Oral and Maxillofacial Surgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coms.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}